Composition: 1 ml of sterile solution contains; 0.1 ± 0.01 mg of CaCl2 and 10⁻¹⁰-10⁻¹¹ mg of a protein-peptide complex isolated from lung tissue of young gobies.
Physiological effect: Viorgon-9 is associated with its property to additionally activate cellular sources of regeneration in tissues, maintain cell viability, as well as adhesive interactions between them.
Recommendations for use: Viorgon-9 is recommended for diseases of the lungs and bronchi (together with viorgons 1, 3 and 31), including during the rehabilitation period after pneumonia, bronchitis, and also fibrosis. Viorgon-9 is combined with other viorgons (especially viorgon-1, viorgon-3 and viorgon-31.
Mode of application
Viorgon can be taken by application to the mucous membrane, intranasally: by instilling into the nasal cavity, or sublingually: by ordering under the tongue. In this case, the dosage starts from 3 drops.
Viorgon can be taken orally, diluting in water at the rate of at least 8-10 drops per 100 ml of water. Drink at least 20-30 minutes before eating or 2 hours after.
A positive effect is observed from the use of 3 or more times a day. An overdose of viorgon preparations is excluded, it is allowed to take as many times a day as they will favorably affect the well-being. The addictive effect is also absent.
The interval between the various viorgons is at least 10 minutes.